| Filed On | Filing |
|---|---|
| 02 Oct 2024 |
Form 3: Nestle Sa, 10% owner and 1 other · Seres Therapeutics, Inc.
Holds 21,879,753 shares of Common Stock, par value $0.001 |
| 12 Mar 2021 | Form 3: Nestle Sa, 10% owner and 1 other · Prometheus Biosciences, Inc. |
| 24 Apr 2020 |
Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 4 others · Aimmune Therapeutics, Inc.
Holds 11,727,113 shares of Common Stock |
| 14 Feb 2020 |
Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 4 others · Axcella Health Inc.
Holds 2,368,699 shares of Common Stock |
| 23 Nov 2016 |
Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Aimmune Therapeutics, Inc.
Holds 7,552,084 shares of Common Stock |
| 25 Jun 2015 |
Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Seres Therapeutics, Inc.
Holds 1,944,444 shares of Common Stock |
| 07 Jul 2005 |
Form 3: Nestle Sa, Director and 2 others · DREYERS GRAND ICE CREAM HOLDINGS INC
Holds 64,564,315 shares of Class B Common Stock, par value $0.01 |
Loading...
